Logo image of FHI

FEDERATED HERMES INC (FHI) Stock Fundamental Analysis

USA - NYSE:FHI - US3142111034 - Common Stock

52.68 USD
0 (0%)
Last: 9/17/2025, 3:45:33 PM
Fundamental Rating

7

Taking everything into account, FHI scores 7 out of 10 in our fundamental rating. FHI was compared to 237 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making FHI a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on FHI. These ratings would make FHI suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year FHI was profitable.
In the past year FHI had a positive cash flow from operations.
FHI had positive earnings in each of the past 5 years.
Each year in the past 5 years FHI had a positive operating cash flow.
FHI Yearly Net Income VS EBIT VS OCF VS FCFFHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

With an excellent Return On Assets value of 16.19%, FHI belongs to the best of the industry, outperforming 96.20% of the companies in the same industry.
Looking at the Return On Equity, with a value of 31.27%, FHI belongs to the top of the industry, outperforming 95.78% of the companies in the same industry.
The Return On Invested Capital of FHI (17.89%) is better than 93.67% of its industry peers.
FHI had an Average Return On Invested Capital over the past 3 years of 16.23%. This is significantly above the industry average of 7.61%.
The last Return On Invested Capital (17.89%) for FHI is above the 3 year average (16.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.19%
ROE 31.27%
ROIC 17.89%
ROA(3y)12.38%
ROA(5y)13.04%
ROE(3y)23.49%
ROE(5y)24.27%
ROIC(3y)16.23%
ROIC(5y)16.25%
FHI Yearly ROA, ROE, ROICFHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of FHI (20.64%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of FHI has declined.
With a Operating Margin value of 28.27%, FHI perfoms like the industry average, outperforming 54.43% of the companies in the same industry.
FHI's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 95.42%, FHI belongs to the best of the industry, outperforming 95.78% of the companies in the same industry.
FHI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.27%
PM (TTM) 20.64%
GM 95.42%
OM growth 3Y-3.42%
OM growth 5Y0.08%
PM growth 3Y-7.67%
PM growth 5Y-4.49%
GM growth 3Y-0.05%
GM growth 5Y-0.31%
FHI Yearly Profit, Operating, Gross MarginsFHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, FHI has less shares outstanding
Compared to 5 years ago, FHI has less shares outstanding
The debt/assets ratio for FHI is higher compared to a year ago.
FHI Yearly Shares OutstandingFHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FHI Yearly Total Debt VS Total AssetsFHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

FHI has an Altman-Z score of 5.08. This indicates that FHI is financially healthy and has little risk of bankruptcy at the moment.
FHI's Altman-Z score of 5.08 is amongst the best of the industry. FHI outperforms 85.65% of its industry peers.
The Debt to FCF ratio of FHI is 1.25, which is an excellent value as it means it would take FHI, only 1.25 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.25, FHI belongs to the best of the industry, outperforming 88.61% of the companies in the same industry.
FHI has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
FHI has a Debt to Equity ratio of 0.31. This is in the better half of the industry: FHI outperforms 72.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.25
Altman-Z 5.08
ROIC/WACCN/A
WACCN/A
FHI Yearly LT Debt VS Equity VS FCFFHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

FHI has a Current Ratio of 3.37. This indicates that FHI is financially healthy and has no problem in meeting its short term obligations.
FHI has a Current ratio of 3.37. This is amongst the best in the industry. FHI outperforms 81.86% of its industry peers.
A Quick Ratio of 3.37 indicates that FHI has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.37, FHI belongs to the best of the industry, outperforming 81.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
FHI Yearly Current Assets VS Current LiabilitesFHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

FHI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.98%, which is quite impressive.
Measured over the past 5 years, FHI shows a small growth in Earnings Per Share. The EPS has been growing by 3.47% on average per year.
Looking at the last year, FHI shows a very negative growth in Revenue. The Revenue has decreased by -15.16% in the last year.
Measured over the past years, FHI shows a small growth in Revenue. The Revenue has been growing by 4.26% on average per year.
EPS 1Y (TTM)54.98%
EPS 3Y3.71%
EPS 5Y3.47%
EPS Q2Q%480%
Revenue 1Y (TTM)-15.16%
Revenue growth 3Y7.92%
Revenue growth 5Y4.26%
Sales Q2Q%5.53%

3.2 Future

Based on estimates for the next years, FHI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.89% on average per year.
FHI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.46% yearly.
EPS Next Y44.87%
EPS Next 2Y21.59%
EPS Next 3Y18.34%
EPS Next 5Y12.89%
Revenue Next Year6.7%
Revenue Next 2Y5.71%
Revenue Next 3Y5.37%
Revenue Next 5Y2.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FHI Yearly Revenue VS EstimatesFHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
FHI Yearly EPS VS EstimatesFHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.68, the valuation of FHI can be described as reasonable.
65.40% of the companies in the same industry are more expensive than FHI, based on the Price/Earnings ratio.
FHI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
The Price/Forward Earnings ratio is 11.17, which indicates a very decent valuation of FHI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FHI indicates a somewhat cheap valuation: FHI is cheaper than 66.24% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.71. FHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.68
Fwd PE 11.17
FHI Price Earnings VS Forward Price EarningsFHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FHI is valued cheaply inside the industry as 92.41% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, FHI is valued a bit cheaper than the industry average as 63.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.71
EV/EBITDA 7.19
FHI Per share dataFHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

FHI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of FHI may justify a higher PE ratio.
FHI's earnings are expected to grow with 18.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.26
PEG (5Y)3.37
EPS Next 2Y21.59%
EPS Next 3Y18.34%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.51%, FHI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 7.96, FHI has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, FHI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.51%

5.2 History

The dividend of FHI is nicely growing with an annual growth rate of 15.47%!
FHI has paid a dividend for at least 10 years, which is a reliable track record.
FHI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)15.47%
Div Incr Years2
Div Non Decr Years3
FHI Yearly Dividends per shareFHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

29.55% of the earnings are spent on dividend by FHI. This is a low number and sustainable payout ratio.
FHI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP29.55%
EPS Next 2Y21.59%
EPS Next 3Y18.34%
FHI Yearly Income VS Free CF VS DividendFHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
FHI Dividend Payout.FHI Dividend Payout, showing the Payout Ratio.FHI Dividend Payout.PayoutRetained Earnings

FEDERATED HERMES INC

NYSE:FHI (9/17/2025, 3:45:33 PM)

52.68

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners82.27%
Inst Owner ChangeN/A
Ins Owners3.98%
Ins Owner Change-1.7%
Market Cap4.09B
Analysts68.33
Price Target50.32 (-4.48%)
Short Float %3.18%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 2.51%
Yearly Dividend2.22
Dividend Growth(5Y)15.47%
DP29.55%
Div Incr Years2
Div Non Decr Years3
Ex-Date08-08 2025-08-08 (0.34)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.49%
Min EPS beat(2)12.16%
Max EPS beat(2)34.82%
EPS beat(4)4
Avg EPS beat(4)16.8%
Min EPS beat(4)5.9%
Max EPS beat(4)34.82%
EPS beat(8)7
Avg EPS beat(8)0.81%
EPS beat(12)10
Avg EPS beat(12)2.9%
EPS beat(16)11
Avg EPS beat(16)0.89%
Revenue beat(2)0
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)-0.49%
Revenue beat(4)1
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)0.11%
Revenue beat(8)1
Avg Revenue beat(8)-0.94%
Revenue beat(12)4
Avg Revenue beat(12)0.06%
Revenue beat(16)5
Avg Revenue beat(16)4.77%
PT rev (1m)5.34%
PT rev (3m)17%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)4.09%
EPS NY rev (1m)3.48%
EPS NY rev (3m)7.74%
Revenue NQ rev (1m)1.08%
Revenue NQ rev (3m)3.09%
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)1.74%
Valuation
Industry RankSector Rank
PE 11.68
Fwd PE 11.17
P/S 2.42
P/FCF 14.71
P/OCF 14.75
P/B 3.67
P/tB N/A
EV/EBITDA 7.19
EPS(TTM)4.51
EY8.56%
EPS(NY)4.72
Fwd EY8.95%
FCF(TTM)3.58
FCFY6.8%
OCF(TTM)3.57
OCFY6.78%
SpS21.76
BVpS14.36
TBVpS-1.2
PEG (NY)0.26
PEG (5Y)3.37
Profitability
Industry RankSector Rank
ROA 16.19%
ROE 31.27%
ROCE 24.77%
ROIC 17.89%
ROICexc 26.13%
ROICexgc 309.43%
OM 28.27%
PM (TTM) 20.64%
GM 95.42%
FCFM 16.46%
ROA(3y)12.38%
ROA(5y)13.04%
ROE(3y)23.49%
ROE(5y)24.27%
ROIC(3y)16.23%
ROIC(5y)16.25%
ROICexc(3y)23.98%
ROICexc(5y)23%
ROICexgc(3y)1021.49%
ROICexgc(5y)802.2%
ROCE(3y)22.48%
ROCE(5y)22.5%
ROICexcg growth 3Y38.23%
ROICexcg growth 5Y38.01%
ROICexc growth 3Y9.02%
ROICexc growth 5Y7%
OM growth 3Y-3.42%
OM growth 5Y0.08%
PM growth 3Y-7.67%
PM growth 5Y-4.49%
GM growth 3Y-0.05%
GM growth 5Y-0.31%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.25
Debt/EBITDA 0.7
Cap/Depr 3.43%
Cap/Sales 0.05%
Interest Coverage 250
Cash Conversion 55.46%
Profit Quality 79.72%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 5.08
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)21%
Cap/Depr(5y)28.99%
Cap/Sales(3y)0.35%
Cap/Sales(5y)0.55%
Profit Quality(3y)126.81%
Profit Quality(5y)111.36%
High Growth Momentum
Growth
EPS 1Y (TTM)54.98%
EPS 3Y3.71%
EPS 5Y3.47%
EPS Q2Q%480%
EPS Next Y44.87%
EPS Next 2Y21.59%
EPS Next 3Y18.34%
EPS Next 5Y12.89%
Revenue 1Y (TTM)-15.16%
Revenue growth 3Y7.92%
Revenue growth 5Y4.26%
Sales Q2Q%5.53%
Revenue Next Year6.7%
Revenue Next 2Y5.71%
Revenue Next 3Y5.37%
Revenue Next 5Y2.46%
EBIT growth 1Y-8.56%
EBIT growth 3Y4.23%
EBIT growth 5Y4.35%
EBIT Next Year42.17%
EBIT Next 3Y14.38%
EBIT Next 5Y8.12%
FCF growth 1Y-12.06%
FCF growth 3Y28.89%
FCF growth 5Y1.38%
OCF growth 1Y-13.73%
OCF growth 3Y26.7%
OCF growth 5Y0.69%